Overview
Lifang Ma practices in Huaihai, China. Ma is rated as an Advanced expert by MediFind in the treatment of Lung Adenocarcinoma. Their top areas of expertise are Lung Adenocarcinoma, Liver Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Tissue Biopsy.
Their clinical research consists of co-authoring 83 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 14 articles in the study of Lung Adenocarcinoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Liver CancerMa isAdvanced. Learn about Liver Cancer.
- Lung Adenocarcinoma
- Lung CancerMa isAdvanced. Learn about Lung Cancer.
- Tissue BiopsyMa isAdvanced. Learn about Tissue Biopsy.
- Experienced
- Anaplastic Thyroid Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- RhabdomyosarcomaMa isExperienced. Learn about Rhabdomyosarcoma.
- Ventricular Septal Defects